Affiliated Cancer Hospital & Institute Of Guangzhou Medical University

This study tests a new combination of drugs for people whose ovarian cancer has returned after standard treatment. The drugs include QL1706 (a dual-target immunotherapy), chemotherapy, and anlotinib (a pill that blocks blood vessel growth to tumors). About 40 participants will re…

This study tests a new drug called QL1706 combined with chemotherapy given before surgery for women with locally advanced cervical cancer. The goal is to see if this combination can completely eliminate the tumor before surgery. About 50 women will take part, and the main measure…